 Eidos Therapeutics Inc NASDAQ:EIDX Equities researchers at Piper Sandler lowered their Q1 2020 earnings per share EPS estimates for shares of Eidos Therapeutics in a research note issued on Wednesday, February 26th. Piper Sandler analyst T. Van. Buren now anticipates that the company will post earnings per share of 0.55 for the quarter, down ... 